JD Supra (press release)Rise Of New CRISPR Inventions: The Toolbox Of Research Applications For CRISPR-Based Systems Continues To …JD Supra (press release)Although much of the reporting around CRISPR tends to focus on its cleavage based ability to kn… Continue reading
JD Supra (press release)Rise Of New CRISPR Inventions: The Toolbox Of Research Applications For CRISPR-Based Systems Continues To …JD Supra (press release)Although much of the reporting around CRISPR tends to focus on its cleavage based ability to kn… Continue reading
Pharmaceuticals NewsSnapshot of the Asian Three-phase Synthetic Biology Market, Forecast to 2024Pharmaceuticals NewsThe report compiled by Zion Market Research offers a forecast on the “Synthetic Biology Market: Global Industry Analysis, Size, Share, … Continue reading
Drug Target ReviewIndex measures similarity between cancer cells and pluripotent stem cellsPhys.OrgThe molecular profiles of embryonic stem cells and tumor cells were compared with the aid of machine learning algorithms, a form of artificial intelligen… Continue reading
MyAJC |
Despite FDA crackdown, stem cell therapy still ‘wild west’
MyAJC At least one clinic appears to advertise treatment that may contradict FDA rules on stem cells derived from umbilical tissue. Still others offering experimental treatments may not have submitted FDA-required investigational new drug applications. The … K9 stem cell study underway in Klamath FallsKOBI-TV NBC5 / KOTI-TV NBC2 Kristine Chapman and Judy Illes: Stem cells claims are ahead of the scienceVancouver Sun Kolkata Boy Part of Stem Cell Study That Offers Hope for AutismThe Quint The Financial all 9 news articles » |
PLoS Blogs (blog) |
Curing the world with CRISPR: Where we are at and where we ‘re …
PLoS Blogs (blog) written by Thomas Clements CRISPR has been hailed as one of the most promising gene editing technologies and promises to revolutionize precision medicine and. Video: How CRISPR can help us feed the worldGenetic Literacy Project Gene-Edited Pigs Better Model Huntington’s Disease | Asian …Asian Scientist Magazine |
|
After $1 Million Drug Flop, UniQure Seeks Gene–Therapy Revival
Bloomberg UniQure is also developing experimental gene therapies for Huntington’s disease and collaborating with Bristol-Myers Squibb Co., which owns about 7.5 percent of the shares, on treatments for cardiovascular illnesses. The company would consider new … |